Monthly Archives: July 2016

BVF Partners L.P., a US-based investor focused on biotechnology investments, acquired shares from pre-IPO venture capital shareholders

By | Uncategorized | No Comments

Molecular Partners was informed that BVF Partners L.P., a US-based investor focused on biotechnology investments, acquired shares from pre-IPO venture capital shareholders and holds 4.58% of the voting rights and share capital of the company. On July 18, 2016, Molecular Partners was also informed that Index Ventures and Essex Woodlands Health Ventures have fallen below the 15% threshold on the same day.

Read More